Integer Holdings Corp (NYSE:ITGR) Expected to Announce Earnings of $1.06 Per Share
Brokerages expect that Integer Holdings Corp (NYSE:ITGR) will announce earnings of $1.06 per share for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Integer’s earnings. The highest EPS estimate is $1.07 and the lowest is $1.05. Integer also reported earnings per share of $1.06 in the same quarter last year. The firm is expected to announce its next quarterly earnings results on Thursday, November 7th.
According to Zacks, analysts expect that Integer will report full-year earnings of $4.40 per share for the current year, with EPS estimates ranging from $4.37 to $4.43. For the next year, analysts anticipate that the firm will report earnings of $4.91 per share, with EPS estimates ranging from $4.85 to $4.97. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow Integer.
Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, August 1st. The medical equipment provider reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.17. The company had revenue of $314.20 million during the quarter, compared to analysts’ expectations of $318.50 million. Integer had a return on equity of 13.31% and a net margin of 15.73%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.06 earnings per share.
In other news, Director Jean M. Hobby sold 6,000 shares of Integer stock in a transaction on Monday, August 5th. The stock was sold at an average price of $80.19, for a total value of $481,140.00. Following the completion of the transaction, the director now directly owns 15,475 shares in the company, valued at $1,240,940.25. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.24% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of ITGR. BlackRock Inc. lifted its stake in Integer by 2.8% during the second quarter. BlackRock Inc. now owns 4,892,982 shares of the medical equipment provider’s stock worth $410,619,000 after purchasing an additional 133,532 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Integer by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 3,924,329 shares of the medical equipment provider’s stock valued at $329,329,000 after acquiring an additional 114,503 shares during the last quarter. FMR LLC lifted its stake in shares of Integer by 118.9% in the 1st quarter. FMR LLC now owns 950,210 shares of the medical equipment provider’s stock valued at $71,664,000 after acquiring an additional 516,080 shares during the last quarter. Silvercrest Asset Management Group LLC lifted its stake in shares of Integer by 22.4% in the 2nd quarter. Silvercrest Asset Management Group LLC now owns 943,985 shares of the medical equipment provider’s stock valued at $79,219,000 after acquiring an additional 172,758 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Integer by 6.3% in the 2nd quarter. Northern Trust Corp now owns 854,642 shares of the medical equipment provider’s stock valued at $71,723,000 after acquiring an additional 51,001 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
NYSE ITGR traded up $0.41 during trading hours on Monday, hitting $77.13. 3,806 shares of the company’s stock were exchanged, compared to its average volume of 223,957. Integer has a 1-year low of $67.72 and a 1-year high of $92.61. The company has a current ratio of 2.42, a quick ratio of 1.41 and a debt-to-equity ratio of 0.78. The stock has a 50-day simple moving average of $78.18 and a 200 day simple moving average of $78.32. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of 20.32 and a beta of 1.07.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Featured Story: What is the float in trading stocks?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.